Authors:
Gimm, O
Dziema, H
Brown, J
De la Puente, A
Hoang-Vu, C
Dralle, H
Plass, C
Eng, C
Citation: O. Gimm et al., Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants, INT J CANC, 92(1), 2001, pp. 70-74
Authors:
Ludwig, L
Kessler, H
Wagner, M
Hoang-Vu, C
Dralle, H
Adler, G
Bohm, BO
Schmid, RM
Citation: L. Ludwig et al., Nuclear factor-kappa B is constitutively active in C-cell carcinoma and required for RET-induced transformation, CANCER RES, 61(11), 2001, pp. 4526-4535
Authors:
Voigt, W
Bulankin, A
Muller, T
Schoeber, C
Grothey, A
Hoang-Vu, C
Schmoll, HJ
Citation: W. Voigt et al., Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines, CLIN CANC R, 6(5), 2000, pp. 2087-2093
Authors:
Mayr, B
Potter, E
Goretzki, P
Ruschoff, J
Dietmaier, W
Hoang-Vu, C
Dralle, H
Brabant, G
Citation: B. Mayr et al., Expression of wild type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany, LANG ARCH S, 384(1), 1999, pp. 54-59
Authors:
Hoang-Vu, C
Bull, K
Schwarz, I
Holtz, J
Schmutzler, C
Kohrle, J
Dralle, H
Citation: C. Hoang-vu et al., Expression of "death-domain"-receptors and their ligands in benign goitre and thyroid carcinoma, LANG ARCH S, 1999, pp. 197-200
Authors:
Gimm, O
Greco, A
Hoang-Vu, C
Dralle, H
Pierotti, MA
Eng, C
Citation: O. Gimm et al., Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma, J CLIN END, 84(8), 1999, pp. 2784-2787